Customs exemption amendments expand tariff exemption coverage for specified drug bulk intermediates used in pharmaceutical manufacture. Directs amendment of specified customs exemption notifications to add named drug bulk intermediates to notification Tables and to omit specified serial entries from certain Schedules, thereby modifying tariff/exemption coverage for the listed pharmaceutical intermediates and related finished products; the changes are effected by textual insertions and deletions in the annexed Tables and Schedules of the cited notifications.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption amendments expand tariff exemption coverage for specified drug bulk intermediates used in pharmaceutical manufacture.
Directs amendment of specified customs exemption notifications to add named drug bulk intermediates to notification Tables and to omit specified serial entries from certain Schedules, thereby modifying tariff/exemption coverage for the listed pharmaceutical intermediates and related finished products; the changes are effected by textual insertions and deletions in the annexed Tables and Schedules of the cited notifications.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
